Molecular Cancer Therapeutics, 1535-7163

Journal

1 - 9 out of 9Page size: 20

Publications

  1. 2015
  2. Published

    Anticancer properties of a novel class of tetrafluorinated thalidomide analogues

    Chris Mahony, Oct 2015, In: Molecular Cancer Therapeutics. 14, 10, p. 2228–2237 10 p.

    Research output: Contribution to journal › Article › peer-review

  3. 2014
  4. Published

    BRCA2 and RAD51 promote double-strand break formation and cell death in response to Gemcitabine

    Rebecca Jones, Panagiotis Kotsantis, Grant Stewart & Eva Petermann, Oct 2014, In: Molecular Cancer Therapeutics. 13, 10, p. 2412-2421

    Research output: Contribution to journal › Article › peer-review

  5. 2012
  6. Published

    Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survival

    Eva Petermann, Jan 2012, In: Molecular Cancer Therapeutics. 11, 1, p. 98-107 10 p.

    Research output: Contribution to journal › Article › peer-review

  7. 2011
  8. Published

    Therapeutic targeting the loss of the birt-hogg-dube suppressor gene

    Xiaohong Lu, Wenbin Wei, Anne Reiman, Zsuzsanna Nagy, Farida Latif & Eamonn Maher, 1 Jan 2011, In: Molecular Cancer Therapeutics. 10, 1, p. 80-9 10 p.

    Research output: Contribution to journal › Article

  9. 2010
  10. Published

    Histone Deacetylase Inhibition Attenuates Cell Growth with Associated Telomerase Inhibition in High-Grade Childhood Brain Tumor Cells

    Andrew Peet, 1 Sep 2010, In: Molecular Cancer Therapeutics. 9, 9, p. 2568-2581 14 p.

    Research output: Contribution to journal › Article

  11. Published

    The NF-KB Inhibitor LC-1 Has Single Agent Activity in Multiple Myeloma Cells and Synergizes with Bortezomib

    Dickens Pratt, 1 Jun 2010, In: Molecular Cancer Therapeutics. 9, 6, p. 1574-1582 9 p.

    Research output: Contribution to journal › Article

  12. Published

    Alisol B, a Novel Inhibitor of the Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase Pump, Induces Autophagy, Endoplasmic Reticulum Stress, and Apoptosis

    Francesco Michelangeli, 1 Mar 2010, In: Molecular Cancer Therapeutics. 9, 3, p. 718-730 13 p.

    Research output: Contribution to journal › Article

  13. 2008
  14. Published

    Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells

    Janet Lord, 1 Apr 2008, In: Molecular Cancer Therapeutics. 7, 4, p. 915-922 8 p.

    Research output: Contribution to journal › Article

  15. Published

    Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography

    Paul Foster, 2008, In: Molecular Cancer Therapeutics. 7, 8, p. 2435-44 10 p.

    Research output: Contribution to journal › Article › peer-review